MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-08-0001891
Multani Pharmaceuticals Limited - fmcg in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹274.25 Cr
▲ 2% YoY
Net profit · FY 2025
₹28.22 Cr
Net margin 10.3%
EBITDA · FY 2025
₹44.29 Cr
EBITDA margin 16.1%
Authorised capital
₹6 Cr
Registered with MCA
Paid-up capital
₹2.16 Cr
Issued & subscribed
Open charges
₹49.85 Cr
Satisfied ₹23.76 Cr
Company age
40 yrs
Est. 1986
Employees · EPFO
812
Provident fund records
About Multani Pharmaceuticals Limited
Data last updated:
Multani Pharmaceuticals Limited is a public limited company based in New Delhi, Delhi, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 05 March 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL1986PLC023539. Its GSTIN is 07AAACM2503K1ZR (Delhi). The company holds 11 GST registrations, all of them active.
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹2.16 Cr. It was formerly known as Multani Pharmaceuticals P Limited. It is led by directors including Rajesh Sabharwal and Sanjay Kumar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at T – 10 Okhla Industrial Area Phase – II, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2025, the company reported a revenue of ₹274.25 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹28.22 Cr (net margin 10.3%) and EBITDA of ₹44.29 Cr (EBITDA margin 16.1%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 13% over five years.
The company has about 812 employees on its provident fund (EPFO) records. Its group structure includes 3 subsidiaries.
The company is associated with 3 brands: Multani Pharmaceuticals, Multani Pharmaceuticals Limited and Multani Pharmaceutical. As per MCA filings, the company has open charges of ₹49.85 Cr and satisfied charges of ₹23.76 Cr on record. Court records list 171 cases involving the company, including 163 filed by the company and 8 filed against it; 16 cases are pending.
Multani Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-08-0001891). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website multani.org.
Company details
CIN U24230DL1986PLC023539
Registration Number 023539
Incorporation Date 05 March 1986
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-08-0001891
Recognitions & Rankings of Multani Pharmaceuticals
Contact details
Multani Pharmaceuticals Limited's registered office is in New Delhi, Delhi. Its website is multani.org. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressT – 10 Okhla Industrial Area Phase – II, New Delhi, Delhi, India – 110020
- IndustryFMCG, Personal Care & Skincare Products
To see the full contact details of Multani Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Multani Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Multani Pharmaceuticals operates multiple associated brands including Multani Pharmaceuticals, Multani Pharmaceuticals Limited, and Multani Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of ayurvedic & herbal medicines | multaniayurved.org | |
| Ayurvedic products manufacturing and sales in India. | multani.org | |
| Testing and manufacturing of Ayurvedic, pharmaceutical, and food products in India. | multanilabs.com |
Business activity
The main business activities of Multani Pharmaceuticals are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other professional, scientific and technical activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Multani Pharmaceuticals Limited, buy the company report.
Financials of Multani Pharmaceuticals Limited
FY 2024 filings availableMultani Pharmaceuticals Limited reported revenue of ₹274.25 Cr (up 2% YoY) for FY 2025.
Revenue · FY 2025
₹274.25 Cr ▲ 2%
Net profit · FY 2025
₹28.22 Cr margin 10.3%
EBITDA · FY 2025
₹44.29 Cr margin 16.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 10%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 4%
5 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 2% growth in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹44.29 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹28.22 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16.1% | ||||
| Net Profit Margin | 10.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Multani Pharmaceuticals Limited, buy the company report.
Board of directors of Multani Pharmaceuticals Limited
Multani Pharmaceuticals has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Sabharwal | Director | 27 Feb 2019 | 7 Years 8 Months | Current |
| Sanjay Kumar Also directs: Nature to Skin Care Private Limited | Director | 01 Feb 2023 | 3 Years 9 Months | Current |
| Pradeep Multani | Director | 08 Mar 1986 | 40 Years 8 Months | Current |
| Yogesh Sahni | Director | 27 Feb 2019 | 7 Years 8 Months | Current |
| Vinay Rungta | Director | 01 Feb 2023 | 3 Years 9 Months | Current |
Auditor
Multani Pharmaceuticals Limited is audited by S.R.DINODIA & CO.LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.R.DINODIA & CO.LLP | FY 2024 | 001478N/N500005 |
Shareholding
The shareholding of Multani Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Multani Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹49.85 Cr
Satisfied charges
₹23.76 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Nov 2025 | 101197301 | Sidbi | ₹2.25 Cr | Open | |
| 04 Nov 2025 | 101193445 | Sidbi | ₹3 Cr | Open | |
| 20 Sep 2025 | 101162442 | Others | ₹20 Cr | Open | |
| 18 Jan 2021 | 100412290 | Sidbi | ₹1.5 Cr | Open | |
| 31 Dec 2002 | 80014710 | Others | ₹23.1 Cr | Open |
To see the full charge records of Multani Pharmaceuticals Limited, buy the company report.
Total charge records: 44 View all charges
Legal cases
Multani Pharmaceuticals Limited has 171 court cases on record: 163 filed by Multani Pharmaceuticals, 8 filed against it. 16 cases are pending and 155 are disposed.
Total cases
171
Filed by the company
163
Filed against the company
8
Pending
16
Disposed
155
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 161 | 6 | 12 |
| High courts | 9 | 1 | 3 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (5 of 171)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (4701-Transfer Petitions : Transfer Petitions under Article 139A(1) of the Constitution of India) | Filed against the company by Union of India and 1 other | Pending |
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Filed by the company against Medicamen Organics Ltd. | Pending |
| High Court of Delhi | Court case (RFA(COMM)) | Filed against the company by Unimarck Healthcare Ltd. | Disposed |
| High Court of Delhi | Commercial suit | Filed by the company against S.A. Herbal Bioactives LLP & Ors. | Disposed |
| District court, West, Delhi | Commercial suit | Filed by the company against Unimarck Healthcare Ltd and 1 other | Disposed |
To see the full case history of Multani Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Multani Pharmaceuticals Limited was last rated by Crisil on 15 Jun 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 15 Jun 2020 |
To see the full credit ratings and regulatory alerts of Multani Pharmaceuticals Limited, buy the company report.
MSME payment delays
Multani Pharmaceuticals Limited has 12 MSME Form 1 returns on record between 2019 and 2023, listing 491 overdue payments to 125 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 125)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ultra Craft Molders Private Limited | |||
| Holosafe Security Labels P.Ltd. | |||
| Pack Seal India Private Limited | |||
| Shree Ganpati Enterprises | |||
| an individual supplier |
To see the full MSME payment records of Multani Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Multani Pharmaceuticals has 3 subsidiary companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
3
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Multani Infra and Agro Private Limited | U01100DL2020PTC374708 | |
| Multani Wellness Private Limited | U20237DL2023PTC410692 | |
| Nature to Skin Care Private Limited | U24299DL2021PTC385340 |
To see the full group structure of Multani Pharmaceuticals Limited, buy the company report.
Employees & EPFO
Multani Pharmaceuticals Limited has a workforce of 812 employees on its EPFO records as of May 2026, across 3 active EPFO establishments.
Employee count
812
Active EPFO establishments
3
Employee growth
17%
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 812 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Multani Pharmaceuticals Limited, buy the company report.
GST
Multani Pharmaceuticals has 11 GST registrations: 11 active. The first 4 active GSTINs are listed below.
Total GSTINs
11
Active
11
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACM2503K1ZR | Delhi | Active | 01 Jul 2017 |
| 07AAACM2503K2ZQ | Delhi | Active | 28 May 2025 |
| 05AAACM2503K1ZV | Uttarakhand | Active | 01 Jul 2017 |
| 09AAACM2503K1ZN | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Multani Pharmaceuticals Limited, buy the company report.
Recent activity
Multani Pharmaceuticals Limited has 12 board changes on record since 1986: 5 appointments and 7 cessations. The latest: Dinesh Rastogi ceased to be Director on 20 Jan 2024.
Charges
A charge with Sidbi amounted to Rs. 2.25 Cr with Charge ID 101197301 was registered on 17 Nov 2025.
Charges
A charge with Sidbi amounted to Rs. 3.00 Cr with Charge ID 101193445 was registered on 04 Nov 2025.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101162442 was registered on 20 Sep 2025.
Charges
A charge registered on 19 Jan 2024 via Charge ID 100848799 with Others was fully satisfied on 03 Apr 2025.
AGM
Multani Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Multani Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Dinesh Rastogi ceased to be Director.
Charges
A charge with Others amounted to Rs. 1.10 Cr with Charge ID 100848799 was registered on 19 Jan 2024.
Charges
A charge with Others of Rs. 23.10 Cr registered on 31 Dec 2002 with Charge ID 80014710 was modified on 08 Aug 2023.
Ceased
Kamal Prasad ceased to be Managing Director.
Appointed
Sanjay Kumar was appointed as Director.
Appointed
Vinay Rungta was appointed as Director.
92 earlier events are in the company report.
Frequently asked questions
Multani Pharmaceuticals is an active public limited company based in New Delhi, Delhi, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 05 March 1986 (40+ years old) and is registered under CIN U24230DL1986PLC023539.
Multani Pharmaceuticals has 5 current directors:
- Rajesh Sabharwal - Director
- Sanjay Kumar - Director
- Pradeep Multani - Director
- Yogesh Sahni - Director
- Vinay Rungta - Director
The latest financial statements of Multani Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Multani Pharmaceuticals is 07AAACM2503K1ZR, registered in Delhi. The company has 11 GST registrations in all, of which 11 are active. Other active GSTINs include 07AAACM2503K2ZQ (Delhi), 05AAACM2503K1ZV (Uttarakhand), 09AAACM2503K1ZN (Uttar Pradesh).
The CIN (Corporate Identification Number) of Multani Pharmaceuticals is U24230DL1986PLC023539. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Multani Pharmaceuticals has 171 court cases on record: 163 filed by the company and 8 filed against it. 16 are pending. Most are in the district courts.
Multani Pharmaceuticals was incorporated on 05 March 1986, making it 40+ years old. It is registered with the Registrar of Companies, Delhi.
Dinesh Rastogi ceased to be Director on 20 Jan 2024. Kamal Prasad ceased to be Managing Director on 02 Feb 2023. Sanjay Kumar was appointed as Director on 01 Feb 2023. Multani Pharmaceuticals has 12 board changes on record in total.
Yes, Multani Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-08-0001891).
Multani Pharmaceuticals has 12 MSME Form 1 returns on record between 2019 and 2023, listing 491 overdue payments to 125 micro and small suppliers. The latest return was filed on 04 Feb 2024.
Multani Pharmaceuticals can be reached through the website multani.org. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages